DCM
NVAX icon

DAFNA Capital Management’s Novavax NVAX Stock Holding History

DAFNA Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-35,000
Closed -$1.32M – 84
2018
Q3 		$1.32M Sell
35,000
-2,500
-7% -$70.4K 0.54% 47
2018
Q2 		$1M Buy
+37,500
New +$1.27M 0.47% 52
2016
Q3 		– Sell
-27,500
Closed -$4M – 90
2016
Q2 		$4M Sell
27,500
-175
-0.6% -$20.1K 3.17% 8
2016
Q1 		$2.86M Buy
+27,675
New +$2.97M 2.46% 11
2013
Q4 		– Sell
-10,500
Closed -$662K – 48
2013
Q3 		$662K Buy
+10,500
New +$591K 0.72% 37

Other funds holding NVAX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return